Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Am J Med Genet ; 103(1): 1-8, 2001 Sep 15.
Article in English | MEDLINE | ID: mdl-11562927

ABSTRACT

We describe a large family from Sardinia, Italy, in which a novel X- linked mental retardation (XLMR) syndrome segregates. The phenotype observed in the 8 affected males includes severe mental retardation (MR), lack of speech, coarse face, distinctive skeletal features with short stature, brachydactyly of fingers and toes, small downslanting palpebral fissures, large bulbous nose, hypoplastic ear lobe and macrostomia. Carrier females are not mentally retarded, although some of them have mild dysmorphic features such as minor ear lobe abnormalities, as well as language and learning problems. Linkage analysis for X-chromosome markers resulted in a maximum lod score of 3.61 with marker DXS1001 in Xq24. Recombination observed with flanking markers identified a region of 16 cM for further study. None of the other XLMR syndromes known to map in the same region shows the same composite phenotype. This evidence strongly suggests that the genetic disease in this family is unique.


Subject(s)
Growth Disorders/pathology , Intellectual Disability/genetics , X Chromosome/genetics , Adolescent , Adult , Chromosome Mapping , Family Health , Female , Fingers/abnormalities , Genetic Linkage , Humans , Intellectual Disability/pathology , Karyotyping , Lod Score , Male , Microsatellite Repeats , Middle Aged , Pedigree , Syndactyly/pathology , Syndrome , Toes/abnormalities
2.
Neurology ; 57(2): 327-30, 2001 Jul 24.
Article in English | MEDLINE | ID: mdl-11468322

ABSTRACT

X-linked isolated lissencephaly sequence (ILS) and subcortical band heterotopia are allelic human disorders associated with mutations of the DCX gene in both familial and sporadic forms. The authors describe a large Sardinian family in which three brothers with ILS have a missense mutation of the DCX gene. Their mother, a nonmosaic carrier, has a normal phenotype and cranial MRI. Skewed X-inactivation in the lymphocytes was also ruled out. This is the first report of an asymptomatic carrier of a DCX mutation likely due to apparent nonpenetrance.


Subject(s)
Brain Diseases/genetics , Brain Diseases/pathology , Brain/pathology , Germ-Line Mutation/genetics , Microtubule-Associated Proteins , Neuropeptides/genetics , Penetrance , X Chromosome/genetics , Adolescent , Child , Child, Preschool , Doublecortin Domain Proteins , Doublecortin Protein , Female , Genetic Linkage/genetics , Humans , Magnetic Resonance Imaging , Pedigree
3.
Headache ; 39(10): 737-46, 1999.
Article in English | MEDLINE | ID: mdl-11284460

ABSTRACT

A multicenter 3-year follow-up study was carried out on young patients with headache referred to tertiary headache centers or pediatric clinics. Three years after the first examination in 1993, 442 (of an original sample of 719) young outpatients with headache (226 females and 216 males) were re-examined. The diagnostic criteria of the International Headache Society (IHS) and those modified for migraine without aura by Winner et al were applied at both the baseline evaluation and the 3-year re-examination. At the follow-up, 290 children still had headache, 101 were in clinical remission, and 51 had dropped out. Using the current diagnostic criteria, only 46.2% of patients having migraine without aura, 50% of those having migraine with aura, and 35.3% of those suffering from migraine disorders which do not fulfill IHS criteria for migraine received the same diagnosis at the time of follow-up. The percentage of patients receiving a diagnosis of migraine without aura rose significantly when new modified criteria were used (60.5%), whereas a drop in the frequency of migraine disorders not fulfilling IHS criteria was observed at follow-up, both in patients with the diagnosis of migraine without aura at the first examination (4.6%) and in patients with migraine not always fulfilling IHS criteria at the first examination (6.2%). Among all patients who received this latter diagnosis at the first examination, it was possible to make a diagnosis of migraine with aura at the follow-up in 8.8% of cases and that of migraine without aura in 26.5%. No significant variations in the frequency of either episodic tension-type headache or chronic tension-type headache were found, with the exception of a slight decrease in the percentage of tension-type headache which did not fulfill IHS criteria, but the difference between the first examination and the follow-up values does not reach the level of statistical significance (5% versus 12%). As far as the evolution of migraine is concerned, 17.4% of patients with migraine were headache-free at the 3-year follow-up. In tension-type headache, the percentage of patients who were headache-free was particularly high in those with the episodic form (32.9%) and in those suffering from tension-type headache not fulfilling IHS criteria (29.1%). The majority of patients who had been diagnosed as having unclassifiable headache at the first examination received a correct diagnosis at the follow-up with the exception of one patient. As observed in adult patients, variations in the headache characteristics were also observed in children and adolescents (that is, migraine with aura can change to migraine without aura, or the latter can transform into episodic tension-type headache or chronic tension-type headache can change into the episodic form). This follow-up study was aimed at reaching a better understanding of headache disturbances in children and adolescents, examining, in particular, variations of headache with time in this stage of life.


Subject(s)
Headache/epidemiology , Outpatients , Adolescent , Child , Child, Preschool , Female , Follow-Up Studies , Headache/classification , Headache/diagnosis , Humans , Incidence , Italy , Male
4.
Brain Dev ; 18(3): 185-91, 1996.
Article in English | MEDLINE | ID: mdl-8836498

ABSTRACT

A study of mitochondrial DNA disease was carried out on 12 members belonging to three generations of a family from northern Sardinia. On the basis of the diagnostic criteria currently used in the classification of mitochondrial diseases a typical MERRF-MELAS overlap phenotype was seen in 11 patients with the mtDNA tRNA(lys) mutation at nucleotide position 8356. Clinical and instrumental investigations (EEG in particular) were made. Patients were divided into two groups: severely and mildly affected cases. The follow-up was reported. The aim of this study was to identify, through EEG, the early signs of the disease. The EEG findings recorded during the clinical evolution allowed us to recognize four degrees of cerebral involvement, and could also suggest the prognosis.


Subject(s)
Electroencephalography , MELAS Syndrome/diagnosis , MERRF Syndrome/diagnosis , Mitochondrial Encephalomyopathies/diagnosis , Adolescent , Adult , Child , Child, Preschool , DNA, Mitochondrial/genetics , Female , Humans , Italy , MELAS Syndrome/genetics , MELAS Syndrome/physiopathology , MERRF Syndrome/genetics , MERRF Syndrome/physiopathology , Male , Middle Aged , Mitochondrial Encephalomyopathies/genetics , Mitochondrial Encephalomyopathies/physiopathology , Pedigree , Phenotype , Point Mutation/physiology , Predictive Value of Tests , Prognosis
5.
Hum Genet ; 96(2): 233-5, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7635478

ABSTRACT

A metachromatic leukodystrophy (MLD) patient affected with the late infantile form was found to be homozygous for an AT-deletion (2324delAT) in the arylsulfatase A gene. The mutation causes a frameshift at the beginning of exon 8 leading to an early termination codon. The parents and unaffected brother of the patient were heterozygous for the microdeletion. The mutation was not detected in another 31 MLD Italian patients. No aberrant transcript caused by the mutation was revealed by the reverse transcription-polymerase chain reaction method.


Subject(s)
Cerebroside-Sulfatase/genetics , Frameshift Mutation , Leukodystrophy, Metachromatic/genetics , Amino Acid Sequence , Base Sequence , Codon, Terminator/genetics , Exons/genetics , Female , Heterozygote , Homozygote , Humans , Infant , Italy/epidemiology , Leukodystrophy, Metachromatic/epidemiology , Male , Molecular Sequence Data , Pedigree , Sequence Deletion
6.
Headache ; 35(3): 146-53, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7721575

ABSTRACT

Seven hundred nineteen young patients attending 21 Italian headache care settings were evaluated by a diagnostic headache interview and a neurological examination. Headache disorders were classified according to the current 1988 criteria of the International Headache Society (IHS); 54.9% of the patients suffered from migraine, 33.9% from tension-type headache, 1.9% from secondary headache, and 3.4% had non-classifiable headache. A further 5.9% of the patients were not classified due to incomplete questionnaires. Of the 395 patients with migraine, 44.5% were affected by migraine without aura, 29.9% by migraine with aura, 1.3% from other migraine forms, and 24.3% by migrainous disorders which do not fulfill the 1988 IHS diagnostic criteria for headache. Among the 244 patients with tension-type headache, 51.6% had episodic tension-type headache, 15.2% chronic tension-type headache, and 33.2% headache of the tension-type which does not fulfill the 1988 IHS criteria for episodic and chronic tension-type headache. In young migraine patients, pain was of a pulsating type in 55.7%, severe in 57.8%, unilateral in 42.6%, and aggravated by routine physical activity in 38.9%. Tension-type headache was described as pressing in 73.8%, mild or moderate in 75.7%, bilateral in 87.4%, and not aggravated by routine physical activity in 85.5%. The duration of pain was less than 2 hours in 35% of the cases in migraine sufferers and less than 30 minutes in 26.7% of tension-type headache sufferers. Nausea, phonophobia, and photophobia were present in at least half of the migraine patients and in one third of tension-type headache patients, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Migraine Disorders/epidemiology , Pain Measurement , Tension-Type Headache/epidemiology , Adolescent , Child , Child, Preschool , Cohort Studies , Female , Humans , Male , Medical History Taking , Migraine Disorders/diagnosis , Migraine Disorders/therapy , Prevalence , Tension-Type Headache/diagnosis , Tension-Type Headache/therapy
7.
Eur Neurol ; 32(3): 141-5, 1992.
Article in English | MEDLINE | ID: mdl-1592070

ABSTRACT

Anticonvulsant therapy was stopped in 191 epileptic children (109 males and 82 females) after a seizure-free period of at least 2 years, independent of EEG findings, followed up for a minimum of 2 years after withdrawal. Overall, 43 (22.5%) had recurrence of seizures; of these, 79% relapsed within the 1st year after drug stopping and 93% within the 2nd year. The probability of remaining seizure free was 97% at the end of the withdrawal period, 82% 1 year later, 79% at 2 years and 77% at 5 years. In order to evaluate the risk of recurrence and the predictive factors of relapse, several parameters were investigated by univariate and multivariate statistical analysis. At univariate analysis, the factors which proved to be significantly correlated to relapses were: age at onset over 4 years, seizure-free time less than 2 years, sudden drug discontinuation, pathological EEG records during seizure-free time and paroxysmal responses to intermittent photic stimulation (IPS). At multivariate analysis, only age at onset, seizure-free time and sudden discontinuation were the factors indicating a significantly higher relapse risk; paroxysmal IPS responses, when analyzed in association with these variables, proved to be significant and increased the predictive value for prognosis of associated factors.


Subject(s)
Anticonvulsants/adverse effects , Electroencephalography/drug effects , Epilepsy/drug therapy , Substance Withdrawal Syndrome/etiology , Adolescent , Anticonvulsants/therapeutic use , Child , Child, Preschool , Epilepsy/chemically induced , Female , Follow-Up Studies , Humans , Infant , Male , Prognosis , Recurrence , Risk Factors
9.
Hum Genet ; 74(1): 74-80, 1986 Sep.
Article in English | MEDLINE | ID: mdl-3463532

ABSTRACT

We previously proposed the hypothesis that the primary expression of the defect in X-linked Duchenne muscular dystrophy (DMD) occurred in the myoblast, or muscle precursor cell. This was based on the observation that the number of viable myoblasts obtained per gram DMD muscle tissue was greatly reduced and those that grew in culture had decreased proliferative capacity and an aberrant distended flat morphology. Here we test that hypothesis by determining whether the expression of the myoblast defect is X-linked. Muscle cells were obtained from five doubly heterozygous carriers of two X-linked loci, DMD and glucose-6-phosphate dehydrogenase (G6PD), and compared with those from five sex- and age-matched controls heterozygous for G6PD only. A total of 1,355 individual clones were determined to be muscle and evaluated at the single cell level for proliferative capacity, morphology, and G6PD isozyme expression. The results demonstrate that the proportion of defective myoblast clones is significantly increased in DMD carriers. However, since this cellular defect does not consistently segregate with a single G6PD phenotype in the myoblast clones derived from any of the carriers, it is unlikely to be the primary expression of the DMD mutant allele.


Subject(s)
Muscular Dystrophies/genetics , X Chromosome , Adult , Cells, Cultured , Female , Genetic Linkage , Genetic Markers , Glucosephosphate Dehydrogenase/genetics , Heterozygote , Humans , Male , Middle Aged , Pedigree
10.
Metab Ophthalmol ; 8(1): 21-5, 1984.
Article in English | MEDLINE | ID: mdl-6521625

ABSTRACT

In inborn errors of metabolism ocular signs can often represent an early symptom and permit a presumed diagnosis which must be confirmed by biochemical studies. Moreover the ocular signs indicate the evolution of the illness together with other general symptoms.


Subject(s)
Eye/pathology , Mucolipidoses/genetics , Adolescent , Child , Child, Preschool , Eye/physiopathology , Female , Humans , Mucolipidoses/enzymology , Mucolipidoses/pathology , Mucolipidoses/physiopathology , Neurologic Manifestations , Pedigree
11.
Eur J Pediatr ; 140(2): 130-3, 1983 Apr.
Article in English | MEDLINE | ID: mdl-6411475

ABSTRACT

Clinical, radiological and biochemical findings of two new cases of Sanfilippo disease, type D are reported. A high percentage of heparan sulfate was found in the urinary glycosaminoglycan pattern and a severe deficiency of N-acetylglucosamine-6-sulfate sulfatase was demonstrated in skin cultured fibroblasts from the patients. One of the patients presented mild intellectual impairment which differentiates him from the other cases described to date.


Subject(s)
Mucopolysaccharidoses/diagnosis , Mucopolysaccharidosis III/diagnosis , Child , Child, Preschool , Female , Fibroblasts/enzymology , Glycosaminoglycans/urine , Heparitin Sulfate/analysis , Humans , Male , Sulfatases/analysis
12.
Epilepsia ; 23(1): 23-6, 1982 Feb.
Article in English | MEDLINE | ID: mdl-6799283

ABSTRACT

Valproic acid (VPA) was determined by EMIT assay in plasma, tears, saliva, and cerebrospinal fluid (CSF) of patients with epilepsy. Closer correlation was shown between tear/plasma and tear/CSF ratios than between saliva/plasma and saliva/CSF ratios. The VPA CSF/serum ratio was in good agreement with data in the literature. Salivary levels were extremely erratic, while those for tears were much more reliable. Determination of VPA in tears is therefore the best method of studying the VPA free fraction in those cases in which investigations of protein binding of the drug are necessary.


Subject(s)
Saliva/analysis , Tears/analysis , Valproic Acid/analysis , Adult , Child , Epilepsy/metabolism , Humans , Immunoenzyme Techniques , Protein Binding , Valproic Acid/blood , Valproic Acid/cerebrospinal fluid
13.
Epilepsia ; 22(2): 185-8, 1981 Apr.
Article in English | MEDLINE | ID: mdl-7472305

ABSTRACT

Diphenylhydantoin (PHT) and primidone (PRM) were determined by the EMIT technique in the plasma, tears, saliva, and CSF of epileptic patients. Results indicate for PHT that tear values are more strictly correlated than are the saliva values to plasma and CSF concentrations. As for PRM, the data obtained show great interindividual variability of concentration in the different body fluids--in agreement with the wide range of both protein binding and half-life of this drug.


Subject(s)
Phenytoin/metabolism , Primidone/metabolism , Tears/analysis , Adult , Child , Epilepsy/metabolism , Female , Humans , Male , Phenytoin/blood , Phenytoin/cerebrospinal fluid , Primidone/blood , Primidone/cerebrospinal fluid , Saliva/analysis
14.
Epilepsia ; 20(6): 705-10, 1979 Dec.
Article in English | MEDLINE | ID: mdl-499116

ABSTRACT

Phenobarbital and carbamazepine concentrations were determined by the EMIT technique in tears, saliva, cerebrospinal fluid (CSF), and plasma of patients with epilepsy. Closer correlation was shown between tear/plasma and tear/CSF ratios than between saliva/plasma and saliva/CSF ratios for the two agents. The phenobarbital CSF/serum ratio was in good agreement with data in the literature, and the higher ratio found for carbamazepine may be caused by an EMIT assay cross-reaction for the free fraction of carbamazepine-10,11-epoxide. In our hands, tears seem to represent the best practical indicator of the unbound fraction of an anticonvulsant drug, and the noninvasiveness of the method makes it specifically useful in pediatric neurology.


Subject(s)
Anticonvulsants/metabolism , Tears/metabolism , Adult , Carbamazepine/metabolism , Child , Epilepsy/metabolism , Female , Humans , Male , Phenobarbital/metabolism , Protein Binding
SELECTION OF CITATIONS
SEARCH DETAIL
...